Immunohistochemistry

KZ Keyun Zhu
BW Baichuan Wang
YL Yingxi Li
YY Yue Yu
ZC Zhaohui Chen
HY Haoran Yue
QM Qingxiang Meng
DT Dongchen Tian
XL Xiaofeng Liu
WS Weiyu Shen
YT Yao Tian
ask Ask a question
Favorite

The tumor samples and the paired normal samples in our hospital were patients suffering from LUAD or LUSC. Tissue sections were deparaffinized, rehydrated, and permeated using Triton X 100 (T8200, Solarbio, Beijing, China) and followed by antigen retrieval using EDTA Antigen Retrieval solution (c1034, Solarbio, Beijing, China). The sections were incubated with Anti-CAV1 antibody (ab32577, Abcam, UK), Anti-CAV2 antibody (ab79397, Abcam, UK), Anti-CAVIN1 antibody (ab48824, Abcam, UK), Anti-CAVIN2 antibody (ab76867, Abcam, UK), Anti-CAVIN3 antibody (ab179923, Abcam, UK) at 4 °C overnight followed by a biotinylated secondary antibody (diluted at 1:200) at RT for 60 min. Then, the sections were stained with DAB staining solution (AR1022, BOSTER Biological Technology, Wuhan, China). To quantitatively evaluate the expression levels of each protein in the samples from patients with LUAD and LUSC, we calculated the percentage of cells stained. The extent of staining was scored as the following criteria: (a) percentage of stained cells: 0 (0%), 1 (1%-25%), 2 (26%-75%), 3 (51%-75%), and 4 (> 75%); and (b) staining intensity: 0 (negative staining), 1 (low staining), 2 (medium staining), and 3 (high staining). The final scores were calculated by multiplying the scores of intensities with that of extent.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A